1
|
Sanga ES, Mbata DD, Msoka EF, Mchome Z, Karia FP, Pollak KI, Robles JM, Schroeder K. The socio-cultural contexts shaping health-seeking behaviours among community members regarding childhood cancer in Tanzania: A qualitative study. Pediatr Blood Cancer 2024; 71:e31278. [PMID: 39238136 DOI: 10.1002/pbc.31278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 07/03/2024] [Accepted: 08/06/2024] [Indexed: 09/07/2024]
Abstract
BACKGROUND Timely diagnosis of childhood cancer, early hospital presentation and completion of treatment significantly improve outcomes. Unfortunately, in Tanzania, thousands of children die of cancer each year without ever being diagnosed or treated. To reduce childhood death from cancer, it is important to understand the social-cultural context, values and beliefs that influence healthcare-seeking behaviours among the Tanzanian community. METHODS This was a cross-sectional qualitative study conducted in Mwanza, Kilimanjaro and Dar-es-Salaam regions between March and June 2021. We purposively selected community members aged ≥18 years from three rural and three urban settings to participate in seven focus group discussions (each with eight to 12 respondents). The participants were from communities without any affiliation to the treatment of children with cancer or treatment facilities. We transcribed, coded and analyzed data using a thematic-content approach with the support of NVIVO 12 software. RESULTS Many had heard of breast or cervical cancer; however, most were unaware of childhood cancer. Adults believe that cancer in children is caused by witchcraft and cannot be cured by modern medicines available at hospitals. These beliefs lead parents to first seek care from traditional healers, which hence delay presentation to the hospital. Other community concerns included the cost of transportation, investigation-related costs, and the long duration of treatment. These have an influence on treatment adherence leading to seeking alternative treatment, such as spiritual or traditional treatment. CONCLUSION Low community awareness, late hospital presentation, and treatment abandonment remain a challenge in childhood cancer in most parts of Tanzania. Belief about childhood cancer being a result of witchcraft and superstition contributes to limited health-seeking behaviours. Cultural and contextually relevant awareness campaign interventions are needed to increase cancer knowledge in Tanzanian communities.
Collapse
Affiliation(s)
- Erica Samson Sanga
- National Institute for Medical Research - Mwanza Centre, Mwanza, Tanzania
| | - Doris D Mbata
- National Institute for Medical Research - Muhimbili Centre, Muhimbili, Tanzania
| | - Elizabeth Francis Msoka
- Kilimanjaro Christian Medical University College, Moshi, Tanzania
- Department of community Health, Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania
| | - Zaina Mchome
- National Institute for Medical Research - Mwanza Centre, Mwanza, Tanzania
| | - Francis P Karia
- Duke Office of Clinical Research (DOCR), School of Medicine, Duke University, Durham, North Carolina, USA
| | - Kathryn I Pollak
- Department of Population Health Sciences, Duke University, School of Medicine, Durham, North Carolina, USA
- Cancer Prevention and Control, Duke Cancer Institute, Durham, North Carolina, USA
| | - Joanna M Robles
- Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
- Cancer Prevention and Control Program, Atrium Health Wake Forest Baptist Comprehensive Cancer Centre, Winston Salem, North Carolina, USA
| | - Kristin Schroeder
- Cancer Prevention and Control, Duke Cancer Institute, Durham, North Carolina, USA
- Pediatric Oncology and Global Health, Duke University School of Medicine, Durham, North Carolina, USA
- Department of Oncology, Bugando Medical Centre, Mwanza, Tanzania
| |
Collapse
|
2
|
Israels T, Borgstein E, Kamiza S, Mallon B, Mavinkurve-Groothuis AMC, Kouya F, Balagadde J, Bhakta N, Renner LA, Ilbawi A, Masamba L, Pritchard-Jones K, Paintsil V, Chagaluka G, Molyneux E. Reflections on 20 years of the Wilms Africa project: Lessons learned and the way forward. Pediatr Blood Cancer 2024:e31386. [PMID: 39397319 DOI: 10.1002/pbc.31386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2024] [Revised: 09/19/2024] [Accepted: 09/30/2024] [Indexed: 10/15/2024]
Abstract
Wilms tumour (WT) is one of the common and curable childhood cancer types included in the Global Initiative for Childhood Cancer (GICC) to monitor progress. Local evidence is key to finding effective and sustainable solutions to local challenges to improve care and survival. Local evidence generated by the Wilms Africa project is summarised with recommendations for the future.
Collapse
Affiliation(s)
- Trijn Israels
- CANCaRe Africa, The Collaborative African Network for Childhood Cancer Care and Research, Blantyre, Malawi
- Paediatrics and Child Health, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
| | - Eric Borgstein
- Paediatric Surgery, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
| | - Steve Kamiza
- Department of Pathology, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
| | - Brenda Mallon
- French African Pediatric Oncology Group (GFAOP), Gustave Roussy, Villejuif, France
| | | | | | - Joyce Balagadde
- Uganda Cancer Institute, Kampala, Uganda
- International Society of Pediatric Oncology - SIOP Africa, Kampala, Uganda
| | - Nickhill Bhakta
- Global Pediatric Medicine Department, St Jude Children's Research Hospital, Memphis, Tennessee, USA
- Adapted Resource and Implementation Application (ARIA), Memphis, Tennessee, USA
| | | | - André Ilbawi
- Technical Officer for Cancer Control, World Health Organisation (WHO), Geneva, Switzerland
| | - Leo Masamba
- International Blantyre Cancer Centre (IBCC), Blantyre, Malawi
| | - Kathy Pritchard-Jones
- Developmental Biology and Cancer Research and Teaching Dept, UCL Great Ormond Street Institute of Child Health, University College London, London, UK
| | - Vivian Paintsil
- Department of Child Health, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
| | - George Chagaluka
- Paediatrics and Child Health, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
| | - Elizabeth Molyneux
- Paediatrics and Child Health, Kamuzu University of Health Sciences (KUHES), Blantyre, Malawi
| |
Collapse
|
3
|
Odunyemi A, Islam MT, Alam K. The financial burden of noncommunicable diseases from out-of-pocket expenditure in sub-Saharan Africa: a scoping review. Health Promot Int 2024; 39:daae114. [PMID: 39284918 PMCID: PMC11405128 DOI: 10.1093/heapro/daae114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/22/2024] Open
Abstract
The growing financial burden of noncommunicable diseases (NCDs) in sub-Saharan Africa (SSA) hinders the attainment of the sustainable development goals. However, there has been no updated synthesis of evidence in this regard. Therefore, our study summarizes the current evidence in the literature and identifies the gaps. We systematically search relevant databases (PubMed, Scopus, ProQuest) between 2015 and 2023, focusing on empirical studies on NCDs and their financial burden indicators, namely, catastrophic health expenditure (CHE), impoverishment, coping strategies, crowding-out effects and unmet needs for financial reasons (UNFRs) in SSA. We examined the distribution of the indicators, their magnitudes, methodological approaches and the depth of analysis. The 71 included studies mostly came from single-country (n = 64), facility-based (n = 52) research in low-income (n = 22), lower-middle-income (n = 47) and upper-middle-income (n = 10) countries in SSA. Approximately 50% of the countries lacked studies (n = 25), with 46% coming from West Africa. Cancer, cardiovascular disease (CVD) and diabetes were the most commonly studied NCDs, with cancer and CVD causing the most financial burden. The review revealed methodological deficiencies related to lack of depth, equity analysis and robustness. CHE was high (up to 95.2%) in lower-middle-income countries but low in low-income and upper-middle-income countries. UNFR was almost 100% in both low-income and lower-middle-income countries. The use of extreme coping strategies was most common in low-income countries. There are no studies on crowding-out effect and pandemic-related UNFR. This study underscores the importance of expanded research that refines the methodological estimation of the financial burden of NCDs in SSA for equity implications and policy recommendations.
Collapse
Affiliation(s)
- Adelakun Odunyemi
- Murdoch Business School, Management & Marketing Department, Murdoch University, 90 South Street, Murdoch, Perth, Western Australia 6150, Australia
- Hospitals Management Board, Clinical Department, Alagbaka, Akure 340223, Ondo State, Nigeria
| | - Md Tauhidul Islam
- Murdoch Business School, Management & Marketing Department, Murdoch University, 90 South Street, Murdoch, Perth, Western Australia 6150, Australia
| | - Khurshid Alam
- Murdoch Business School, Management & Marketing Department, Murdoch University, 90 South Street, Murdoch, Perth, Western Australia 6150, Australia
| |
Collapse
|
4
|
Kruger M, van Elsland SL, Davidson A, Stones D, du Plessis J, Naidu G, Geel J, Poole J, Schoeman J, Stannard C, Mustak H, van Zyl A, Wetter J, Lecuona K. Outcome of Retinoblastoma After Implementation of National Retinoblastoma Treatment Guidelines in South Africa. JCO Glob Oncol 2024; 10:e2400034. [PMID: 39208391 DOI: 10.1200/go.24.00034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Revised: 06/04/2024] [Accepted: 07/24/2024] [Indexed: 09/04/2024] Open
Abstract
PURPOSE Retinoblastoma, a curable childhood cancer, has been identified as a tracer cancer in the WHO Global Initiative for Childhood Cancer. To document the outcomes of children with retinoblastoma in South Africa, treated as per the first prospective standard national treatment guidelines for childhood cancer in South Africa. PATIENTS AND METHODS All children diagnosed with retinoblastoma between 2012 and 2016 in five South African pediatric oncology units were treated with a standard treatment on the basis of the International Society of Pediatric Oncology-Pediatric Oncology in Developing Countries guidelines for high-income settings. Treatment included focal therapy with/without chemotherapy, or enucleation with/without chemotherapy, and orbital radiotherapy, depending on enucleated eye histology. The end point was survival at 24 months, using Kaplan-Meier curves with log-rank (Mantel-Cox) and chi-square (χ2) tests with respective P values reported. RESULTS A total of 178 children were included in the study; 68% presented with unilateral disease. The median age was 27 months (range 0-118 months) with a male:female ratio of 1:0.75. The overall survival was 79% at 24 months with significant association with stage at diagnosis (P < .001) and older age over 2 years as opposed to younger than 2 years (P < .001). Causes of death were disease progression/relapses in 90% (34 of 38) and unknown in 2% (1 of 38), whereas treatment abandonment was 1.7% (3 of 178). CONCLUSION Efficacy with national treatment guidelines was confirmed, and feasibility of implementing standard national childhood cancer treatment guidelines was documented, involving multidisciplinary teams in South Africa. Outcome was significantly associated with stage at diagnosis and age.
Collapse
Affiliation(s)
- Mariana Kruger
- Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- Tygerberg Hospital, Cape Town, South Africa
| | - Sabine L van Elsland
- Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- Tygerberg Hospital, Cape Town, South Africa
- MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
| | - Alan Davidson
- Haematology-Oncology Service, Department of Pediatrics and Child Health, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa
| | - David Stones
- Department of Pediatrics, University of the Free State, Bloemfontein, South Africa
- Universitas Hospital, Bloemfontein, South Africa
| | - Jan du Plessis
- Department of Pediatrics, University of the Free State, Bloemfontein, South Africa
- Universitas Hospital, Bloemfontein, South Africa
| | - Gita Naidu
- Department of Pediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa
- Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
| | - Jennifer Geel
- Division of Pediatric Hematology Oncology, Department of Pediatrics and Child Health, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa
- Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
| | - Janet Poole
- Division of Pediatric Hematology Oncology, Department of Pediatrics and Child Health, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa
- Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
| | - Judy Schoeman
- Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- Tygerberg Hospital, Cape Town, South Africa
| | - Clare Stannard
- Department Radiation Oncology, Groote Schuur Hospital, Cape Town, South Africa
- Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Hamzah Mustak
- Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Department of Ophthalmology, Groote Schuur Hospital, Cape Town, South Africa
| | - Anel van Zyl
- Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- Tygerberg Hospital, Cape Town, South Africa
| | - Julie Wetter
- Department Radiation Oncology, Groote Schuur Hospital, Cape Town, South Africa
- Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
| | - Karin Lecuona
- Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- Department of Ophthalmology, Groote Schuur Hospital, Cape Town, South Africa
| |
Collapse
|
5
|
Atwiine B, Mdoka C, Branchard M, Chagaluka G, Fufa D, Ayalew M, Khofi H, Amankwah E, Chokwenda N, Birhane F, Mezgebu E, Eklu B, Jator B, Kudowa E, Mbah G, Wassie M, Dondo V, Paintsil V, Pritchard-Jones K, Renner LA, Sung L, Kouya F, Molyneux E, Chitsike I, Israels T. Prevention of treatment abandonment remains an important challenge to increase survival of Wilms tumor in sub-Saharan Africa: A report from Wilms Africa-CANCaRe Africa. Pediatr Blood Cancer 2024; 71:e31069. [PMID: 38773703 DOI: 10.1002/pbc.31069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 04/21/2024] [Accepted: 04/29/2024] [Indexed: 05/24/2024]
Abstract
BACKGROUND The Wilms Africa studies implemented an adapted Wilm's tumor (WT) treatment protocol in sub-Saharan Africa in two phases. Phase I began with four sites and provided out-of-pocket costs. Phase II expanded the number of sites, but lost funding provision. Objective is to describe the outcomes of Phase II and compare with Phase I. METHODS Wilms Africa Phase I (n = 4 sites; 2014-2018) and Phase II (n = 8 sites; 2021-2022) used adapted treatment protocols. Funding for families' out-of-pocket costs was provided during Phase I but not Phase II. Eligibility criteria were age less than 16 years and newly diagnosed unilateral WT. We documented patients' outcome at the end of planned first-line treatment categorized as treatment abandonment, death during treatment, and disease-related events (death before treatment, persistent disease, relapse, or progressive disease). Sensitivity analysis compared outcomes in the same four sites. RESULTS We included 431 patients in Phase I (n = 201) and Phase II (n = 230). The proportion alive without evidence of disease decreased from 69% in Phase I to 54% in Phase II at all sites (p = .002) and 58% at the original four sites (p = .04). Treatment abandonment increased overall from 12% to 26% (p < .001), and was 20% (p = .04) at the original four sites. Disease-related events (5% vs. 6% vs. 6%) and deaths during treatment (14% vs. 14% vs. 17%) were similar. CONCLUSION Provision of out-of-pocket costs was important to improve patient outcomes at the end of planned first-line treatment in WT. Prevention of treatment abandonment remains an important challenge.
Collapse
Affiliation(s)
| | - Cecilia Mdoka
- The Collaborative African Network for Childhood Cancer Care and Research, CANCaRe Africa, Blantyre, Malawi
| | | | - George Chagaluka
- Paediatrics and Child Health, Kamuzu University of Health sciences (KUHES), Blantyre, Malawi
| | - Diriba Fufa
- Pediatrics and Child Health, Jimma University, Jimma, Ethiopia
| | - Mulugeta Ayalew
- Unit of Pediatric Hematology Oncology, University of Gondar Specialized Hospital, Gondar, Ethiopia
| | - Harriet Khofi
- The Collaborative African Network for Childhood Cancer Care and Research, CANCaRe Africa, Blantyre, Malawi
- Paediatrics and Child Health, Kamuzu University of Health sciences (KUHES), Blantyre, Malawi
| | | | | | - Feven Birhane
- Unit of Pediatric Hematology Oncology, University of Gondar Specialized Hospital, Gondar, Ethiopia
| | | | - Bernice Eklu
- Paediatric Oncology, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | - Brian Jator
- Paediatrics, Mbingo Baptist Hospital, Mbingo, Cameroon
| | - Evaristar Kudowa
- Department of Statistics, Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi
| | - Glenn Mbah
- Paediatrics, Mbingo Baptist Hospital, Mbingo, Cameroon
| | - Mulugeta Wassie
- Unit of Pediatric Hematology Oncology, University of Gondar Specialized Hospital, Gondar, Ethiopia
| | - Vongai Dondo
- Pediatrics, College of Health Sciences, Harare, Zimbabwe
| | - Vivian Paintsil
- Paediatric Oncology, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | | | | | - Lillian Sung
- Sick Children's Hospital, Toronto, Ontario, Canada
| | | | - Elizabeth Molyneux
- Paediatrics and Child Health, Kamuzu University of Health sciences (KUHES), Blantyre, Malawi
| | - Inam Chitsike
- Pediatrics, College of Health Sciences, Harare, Zimbabwe
| | - Trijn Israels
- The Collaborative African Network for Childhood Cancer Care and Research, CANCaRe Africa, Blantyre, Malawi
- Paediatrics and Child Health, Kamuzu University of Health sciences (KUHES), Blantyre, Malawi
| |
Collapse
|
6
|
Chiwanga F, Woodford J, Masika G, Richards DA, Savi V, von Essen L. Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed-methods study protocol. Cancer Med 2024; 13:e70034. [PMID: 39041493 PMCID: PMC11264114 DOI: 10.1002/cam4.70034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 07/02/2024] [Accepted: 07/09/2024] [Indexed: 07/24/2024] Open
Abstract
BACKGROUND Public contribution in research can lead to the design and conduct of more feasible and relevant research. However, our understanding of the acceptability and feasibility of public contribution and the evidence base regarding its impact in low- and middle-income countries (LMICs) is limited. METHODS In this study protocol, we describe a mixed-method examination of public contribution activities in the GuardiansCan project. The GuardiansCan project aims to respond to Tanzanian guardians' poor adherence to children's follow-up care after treatment for acute lymphoblastic leukemia (ALL) with the help of Mobile Health technology. We aim to: (1) involve guardians of children treated for ALL as Guardians Advisory Board (GAB) members in the managing and undertaking, analysis and interpretation, and dissemination phases of the GuardiansCan project; and (2) examine the acceptability, feasibility, and perceived impact of GAB members' contribution to the GuardiansCan project from the perspective of the GAB members and public contribution coordinators. We will recruit six to eight guardians of children treated for ALL to the GAB. We will hold workshops where GAB members contribute to all project phases. Using impact logs, we will record GAB workshop activities and the perceived impact of these activities. We will interview GAB members and public contribution coordinators 6 months after establishing the GAB, and at the end of each study within the project, to examine the acceptability, feasibility, and perceived impact of public contribution activities. DISCUSSION We expect GAB contribution to increase project quality and relevance, and inform how to best embed public contribution in research in LMICs.
Collapse
Affiliation(s)
- Faraja Chiwanga
- Muhimbili National Hospital, Research and Consultancy UnitDar es SalaamUnited Republic of Tanzania
- Department of Women's and Children's Health, Healthcare Sciences and e‐HealthUppsala UniversityUppsalaSweden
| | - Joanne Woodford
- Department of Women's and Children's Health, Healthcare Sciences and e‐HealthUppsala UniversityUppsalaSweden
| | - Golden Masika
- Department of Clinical NursingUniversity of DodomaDodomaUnited Republic of Tanzania
| | - David A. Richards
- Department of Women's and Children's Health, Healthcare Sciences and e‐HealthUppsala UniversityUppsalaSweden
- Department of Health and Caring SciencesWestern Norway University of Applied SciencesBergenNorway
| | - Victor Savi
- Department of Women's and Children's Health, Healthcare Sciences and e‐HealthUppsala UniversityUppsalaSweden
| | - Louise von Essen
- Department of Women's and Children's Health, Healthcare Sciences and e‐HealthUppsala UniversityUppsalaSweden
| |
Collapse
|
7
|
Nanteza S, Yap A, Stephens CQ, Kambagu JB, Kisa P, Kakembo N, Fadil G, Nimanya SA, Okello I, Naluyimbazi R, Mbwali F, Kayima P, Ssewanyana Y, Grabski D, Naik-Mathuria B, Langer M, Ozgediz D, Sekabira J. Treatment abandonment in children with Wilms tumor at a national referral hospital in Uganda. Pediatr Surg Int 2024; 40:162. [PMID: 38926234 PMCID: PMC11208238 DOI: 10.1007/s00383-024-05744-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/12/2024] [Indexed: 06/28/2024]
Abstract
INTRODUCTION The incidence of pediatric Wilms' tumor (WT) is high in Africa, though patients abandon treatment after initial diagnosis. We sought to identify factors associated with WT treatment abandonment in Uganda. METHODS A cohort study of patients < 18 years with WT in a Ugandan national referral hospital examined clinical and treatment outcomes data, comparing children whose families adhered to and abandoned treatment. Abandonment was defined as the inability to complete neoadjuvant chemotherapy and surgery for patients with unilateral WT and definitive chemotherapy for patients with bilateral WT. Patient factors were assessed via bivariate logistic regression. RESULTS 137 WT patients were included from 2012 to 2017. The mean age was 3.9 years, 71% (n = 98) were stage III or higher. After diagnosis, 86% (n = 118) started neoadjuvant chemotherapy, 59% (n = 82) completed neoadjuvant therapy, and 55% (n = 75) adhered to treatment through surgery. Treatment abandonment was associated with poor chemotherapy response (odds ratio [OR] 4.70, 95% confidence interval [CI] 1.30-17.0) and tumor size > 25 cm (OR 2.67, 95% CI 1.05-6.81). CONCLUSIONS Children with WT in Uganda frequently abandon care during neoadjuvant therapy, particularly those with large tumors with poor response. Further investigation into the factors that influence treatment abandonment and a deeper understanding of tumor biology are needed to improve treatment adherence of children with WT in Uganda.
Collapse
Affiliation(s)
- Sumayiya Nanteza
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | - Ava Yap
- Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA.
| | - Caroline Q Stephens
- Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA
| | | | - Phyllis Kisa
- Department of Pediatric Surgery, Makerere University College of Health and Sciences, Kampala, Uganda
| | - Nasser Kakembo
- Department of Pediatric Surgery, Makerere University College of Health and Sciences, Kampala, Uganda
| | - Geriga Fadil
- Department of Hematology Oncology, Ugandan Cancer Institute, Kampala, Uganda
| | - Stella A Nimanya
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | - Innocent Okello
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | | | - Fiona Mbwali
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | - Peter Kayima
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | - Yasin Ssewanyana
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| | - David Grabski
- Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA
| | - Bindi Naik-Mathuria
- Department of Pediatric Surgery, The University of Texas Medical Branch at Galveston, Webster, TX, USA
| | - Monica Langer
- Department of Pediatric Surgery, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - Doruk Ozgediz
- Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA
| | - John Sekabira
- Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda
| |
Collapse
|
8
|
Marfo M, Acheampong AK, Asare C. Financial burden faced by breastfeeding mothers caring for children diagnosed with cancer in Ghana; an exploratory qualitative study. BMC Womens Health 2024; 24:177. [PMID: 38486146 PMCID: PMC10938724 DOI: 10.1186/s12905-024-02931-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2023] [Accepted: 01/25/2024] [Indexed: 03/18/2024] Open
Abstract
BACKGROUND When children are diagnosed of cancer, parents face varied financial issues. Among some of the identifiable factors that cause financial challenges among breastfeeding mothers include the high cost of childhood cancer care. The high cost of childhood cancer care could impede the sustainability of access to prompt care. There is paucity of literature on the financial burdens faced by breastfeeding mothers with children diagnosed with cancer in Ghana. Therefore, this study sought to explore the financial burden faced by mothers with breastfeeding children diagnosed with cancer. METHODS The study employed qualitative exploratory descriptive design. One-on-one interviews were conducted among 13 mothers with breastfeeding children diagnosed of cancer. Permission was sought for data to be recorded, transcribed concurrently and inductive content analysis done. RESULTS Three main themes emerged after data analysis: High cost (sub-themes; expensive medications, laboratory investigation fees, and cost of mothers' feeding), Public support (sub-themes; appeal for funds, national health insurance scheme) and Self-financing (loans, personal savings). Most of the breastfeeding mothers narrated that high cost of childhood cancer care generated financial distress to them. They shared that the cost involved in purchasing their children's cancer medications, paying for laboratory investigations and feeding themselves to produce adequate breastmilk to feed their children were challenging. Some of the mothers self-financed the cost of their children's cancer care through loans and personal savings. CONCLUSION Government and other stakeholders should allocate annual budget and funds towards childhood cancer care to lessen the financial burden breastfeeding mothers caring for children with cancer experience.
Collapse
Affiliation(s)
- Margaret Marfo
- School of Nursing and Midwifery, Wisconsin International University College-Ghana, Accra, Ghana
| | | | - Comfort Asare
- School of Nursing and Midwifery, Wisconsin International University College-Ghana, Accra, Ghana
| |
Collapse
|
9
|
Hesseling PB, Afungchwi GM, Njodzeka BW, Wharin P, Kouya FN, Kruger M. Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon. PLoS One 2024; 19:e0299777. [PMID: 38466670 PMCID: PMC10927099 DOI: 10.1371/journal.pone.0299777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Accepted: 02/14/2024] [Indexed: 03/13/2024] Open
Abstract
INTRODUCTION The role of age and sex in the presentation and outcome of endemic Burkitt lymphoma (BL) has not been studied recently. This study analysed these factors in 934 patients with BL who had received cyclophosphamide and intrathecal methotrexate as treatment. METHODS Records of 934 children diagnosed with BL from 2004 to 2015 were obtained from our Paediatric Oncology Networked Database (POND) cancer registry. Age at diagnosis, sex, disease stage, time to diagnosis, delay in diagnosis, completion of treatment, rate of abandonment, and one-year survival rates were recorded and statistically analysed. RESULTS The male to female ratio of 1.41 for the study population of 934. The median delay from onset of symptoms to diagnosis was 31 days. The St Jude stage distribution was I = 6.4%, II = 5.9%, III = 71.5% and IV = 16.2%. Significantly more patients presented with stage III disease in age groups 5-9 and 10-14 years than 0-4 years. The overall 1-year survival rate was 53.45%, respectively 77.1% for stage I, 67.9% for stage II, 55.1% for stage III and 32.4% for stage IV disease (p<0.001). There was no significant difference in survival by sex and age group. CONCLUSION Patients aged under 5 years presented with less-advanced disease, but survival was not affected by age. Sex did not influence delay to diagnosis and overall survival. The long delay between the onset of symptoms and diagnosis emphasises the need for interventions to achieve an earlier diagnosis and a better survival rate.
Collapse
Affiliation(s)
- Peter Bernard Hesseling
- Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
| | - Glenn Mbah Afungchwi
- Department of Nursing and Midwifery, The University of Bamenda, Bamenda, Cameroon
| | | | - Paul Wharin
- Beryl Thyer Memorial Africa Trust, Burton Latimer, United Kingdom
| | | | - Mariana Kruger
- Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
| |
Collapse
|
10
|
Monko DJ, Martin HD, Mpolya EA. Correlating food and nutritional patterns with cancers in the pediatric oncology population at two specialized hospitals in Tanzania. BMC Nutr 2024; 10:10. [PMID: 38212830 PMCID: PMC10782733 DOI: 10.1186/s40795-024-00824-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2023] [Accepted: 01/05/2024] [Indexed: 01/13/2024] Open
Abstract
BACKGROUND This study of nutritional patterns in relation to cancers among pediatric oncology population in Tanzania was motivated by the lack of up-to-date information about the nutritional practices, the controversy around the importance of nutritional support and the lack of consistent nutritional criteria among pediatric oncology populations. METHODS A survey study in two cancer referral hospitals of children diagnosed with any cancers, aged between 1 and 17 years inclusive and being eligible for enteral feeding included 131 children. Their demographic, nutritional, feeding and cancer profiles were analyzed descriptively through mapping and other approaches as well as inferentially using multinomial regression models to understand different aspects of nutrition for children suffering from cancers. RESULTS The majority (15% or higher) of pediatric oncology population originated from the lake zone. Between 7 and 12% of pediatric oncology population originated from the Western zone. The top-three cancers with their percentages in the brackets were: Wilms Tumor (32%), Acute Lymphoblastic Leukemia (26%) and Retinoblastoma (13%). About 69% of the pediatric oncology population ate foods that are rich in energy but poor in protein such as rice (21.5%), porridge (19.3%), banana (11.7%) and potatoes (10.2%). On the other hand, only 17.5% ate foods that are generally protein-rich such as meat (8.0%), fish (5.3%) and chicken (4.2%); and 12.7% ate milk (4.2%), beans (3.4%), vegetables (2.7%), eggs (1.9%) and fruits (1.5%). Cancers impacted food intake in about 60% of all children with cancers and affected appetite in 18.3% of them. Cancers caused vomiting in 16% and diarrhea in 6.1% of children. The majority of children with cancers (61.8%) took at least one meal while 34.4% took just snacks (p < 0.001). CONCLUSIONS The majority of pediatric oncology population had erratic nutritional patterns and took foods high in energy and poor in proteins. There is a two-way interaction between cancers and nutrition in which cancers affect general nutritional intake which could affect the cancer treatment outcomes in return. Therefore, it is important to consider these interactions while managing pediatric oncology populations in this and similar settings.
Collapse
Affiliation(s)
- Dafrosa Joseph Monko
- Department of Food and Nutritional Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, 447, Arusha, Tengeru, Tanzania.
- Bugando Medical Center, Wurzburg Street, 1370, Mwanza, Tanzania.
| | - Haikael David Martin
- Department of Food and Nutritional Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, 447, Arusha, Tengeru, Tanzania
| | - Emmanuel Abraham Mpolya
- Department of Global Health and Bio-Medical Sciences, S chool of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, 447, Arusha, Tengeru, Tanzania
- Institute of Bioaffiliationersity, Animal Health & Comparative Medicine, University of Glasgow, G12 8QQ, Glasgow, Scotland, UK
- Center for Global Health (CGH), Perelman School of Medicine, University of Pennsylvania, 240 John Morgan Bldg, 3620, 19104, Hamilton Walk, Philadelphia, PA, USA
- Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, 3980 15th Ave. NE, UW Campus Box #351615, 98195, Seattle, WA, USA
| |
Collapse
|
11
|
Phiri L, Li WHC, Phiri PGMC, Cheung AT, Wanda‐Kalizang'oma W, Kamwendo A, Lemon S. Experiences of caregivers of children with cancer in Malawi: A qualitative study. Cancer Med 2024; 13:e6963. [PMID: 38379330 PMCID: PMC10844995 DOI: 10.1002/cam4.6963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/05/2024] [Accepted: 01/12/2024] [Indexed: 02/22/2024] Open
Abstract
BACKGROUND Studies have shown that caregivers of children with cancer experience challenges when caring for their children. To date, no studies have examined the experience of caregivers of children with cancer in Malawi, a low-income country in sub-Saharan Africa. Hence, this study aimed to explore the experiences of caregivers of Malawian children receiving cancer treatment. METHODS This explorative qualitative study used semi-structured interviews to collect data from 22 caregivers of children receiving cancer treatment. The data were analysed using qualitative content analysis. RESULTS Five themes emerged from the QCA. The caregivers perceived their children's cancer as a burden, a form of psychological torture and a disruptor of family routines and social lifestyles. They also reported self-isolation due to the stigma that they faced in the course of caring for their children and a need for informational, psychosocial, spiritual and financial support. CONCLUSION Caregivers of Malawian children with cancer experience physical and psychosocial challenges as they are caring for their children with cancer. Developing appropriate interventions would enable nurses to offer optimal support to these caregivers in dealing with these challenges and meeting their needs effectively.
Collapse
Affiliation(s)
- Lophina Phiri
- The Nethersole School of Nursing, Faculty of MedicineThe Chinese University of Hong KongShatinNew TerritoriesHong Kong
| | - William Ho Cheung Li
- The Nethersole School of Nursing, Faculty of MedicineThe Chinese University of Hong KongShatinNew TerritoriesHong Kong
| | - Patrick G. M. C. Phiri
- Institute of Applied Technology, Fatima College of Health SciencesAl AinAbu DhabiUnited Arab Emirates
| | - Ankie Tan Cheung
- The Nethersole School of Nursing, Faculty of MedicineThe Chinese University of Hong KongShatinNew TerritoriesHong Kong
| | | | | | - Sellina Lemon
- Baylor College of Medicine Childrens Foundation, Global HOPE ProjectLilongweMalawi
| |
Collapse
|
12
|
Sichali J, Denburg A, Khofi H, Mdoka C, Nyirenda D, Chimalizeni Y, Chagaluka G, Molyneux E, Henrion MYR, Gupta S, Israels T. Prevention of treatment abandonment in sub-Saharan Africa; Lessons learned in Malawi that guide the way forward to cost-effective interventions: A report from CANCaRe Africa. Pediatr Blood Cancer 2023; 70:e30654. [PMID: 37644661 DOI: 10.1002/pbc.30654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 07/29/2023] [Accepted: 08/21/2023] [Indexed: 08/31/2023]
Affiliation(s)
- Junious Sichali
- Department of Paediatrics, Collaborative African Network for Childhood Cancer Care and Research (CANCaRe Africa), Blantyre, Malawi
| | - Avi Denburg
- Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Harriet Khofi
- Kamuzu University of Health Sciences (KUHeS), Blantyre, Malawi
| | - Cecilia Mdoka
- Department of Paediatrics, Collaborative African Network for Childhood Cancer Care and Research (CANCaRe Africa), Blantyre, Malawi
| | | | | | | | | | - Marc Y R Henrion
- Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi
- Liverpool School of Tropical Medicine, Liverpool, UK
| | - Sumit Gupta
- Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Trijn Israels
- Department of Paediatrics, Collaborative African Network for Childhood Cancer Care and Research (CANCaRe Africa), Blantyre, Malawi
| |
Collapse
|
13
|
Baissa OT, Hailu W, Tadesse F, Abubeker A, Aman MA, Fufa D, Paltiel O. Attitude, Perceived Barriers, and Challenges Toward Implementing Resource-Appropriate Guidelines for Hematologic Malignancies: Physicians' Survey in Ethiopia. JCO Glob Oncol 2023; 9:e2300104. [PMID: 37797282 PMCID: PMC10664861 DOI: 10.1200/go.23.00104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 07/12/2023] [Accepted: 08/18/2023] [Indexed: 10/07/2023] Open
Abstract
PURPOSE Cancer care in low-income countries poses formidable challenges. Care may be facilitated by resource-adapted guidelines, such as the National Comprehensive Cancer Network (NCCN) harmonized guidelines for sub-Saharan Africa (NCCN-HG). Understanding physicians' attitudes and knowledge toward guidelines, as well as patient- and resource-related barriers, is essential for promoting their effective implementation. METHODS We conducted an online survey among oncologists, hematologists, internists, residents/fellows, and generalists treating hematologic malignancies in Ethiopia. We assessed attitudes toward the use of guidelines, institutional capacity, and barriers/determinants to effective care. RESULTS Among the 47 physicians completing the survey (representing 64% of Ethiopian professionals treating hematologic malignancies), the majority (85%) reported using guidelines; however, only 22.7% (n = 10) used the NCCN-HG. While overall attitudes toward guidelines were favorable, 57.8% of physicians familiar with the NCCN-HG were either undecided or believed that it lowers the standard of care. Perceived lack of institutional regulation was negatively associated with guideline use (B = -3.23; P = .004). Lack of diagnostic facilities including immunohistochemistry and flow cytometry, supportive care, and poor utilization of guidelines were reported to be determinants of poor patient outcome. Regarding patient factors, 57.4% respondents identified treatment abandonment as an important contributor to poor outcome. Availability of chemotherapy/radiotherapy (89.4%), financial status (85.1%), distance from the hospital (74.5%), and harvest season (65%) had major influences on treatment decisions. Over 80% reported that targeted therapies were unavailable or rarely available. CONCLUSION Awareness and usage of the NCCN-HG are limited among Ethiopian physicians. Lack of facilities, therapies, and regulation, in addition to patient-related factors, was identified as barriers to guideline adherence and determinants of poor outcome.
Collapse
Affiliation(s)
- Obsie T. Baissa
- Faculty of Medicine, Braun School of Public Health Community Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, Jerusalem, Israel
| | - Workagegnehu Hailu
- Department of Medicine, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia
| | - Fisihatsion Tadesse
- Department of Medicine, College of Health Sciences, Addis Ababa University, Ababa, Ethiopia
| | - Abdulaziz Abubeker
- Department of Medicine, College of Health Sciences, Addis Ababa University, Ababa, Ethiopia
| | - Munir Awol Aman
- Department of Oncology, College of Health Sciences, Addis Ababa University, Ababa, Ethiopia
| | - Diriba Fufa
- Department of Pediatrics, Institute of Health Science, Jimma University, Jimma, Ethiopia
| | - Ora Paltiel
- Faculty of Medicine, Braun School of Public Health Community Medicine, Hadassah Medical Organization, Hebrew University of Jerusalem, Jerusalem, Israel
| |
Collapse
|
14
|
Holmes DM, Matatiyo A, Mpasa A, Huibers MHW, Manda G, Tomoka T, Mulenga M, Namazzi R, Mehta P, Zobeck M, Mzikamanda R, Chintagumpala M, Allen C, Nuchtern JG, Borgstein E, Aronson DC, Ozuah N, Nandi B, McAtee CL. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities. Pediatr Blood Cancer 2023; 70:e30242. [PMID: 36798020 PMCID: PMC10698850 DOI: 10.1002/pbc.30242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 01/07/2023] [Accepted: 01/18/2023] [Indexed: 02/18/2023]
Abstract
INTRODUCTION Wilms tumor therapy in low- and middle-income countries (LMICs) relies on treatment protocols adapted to resource limitations, but these protocols have rarely been evaluated in real-world settings. Such evaluations are necessary to identify high-impact research priorities for clinical and implementation trials in LMICs. The purpose of this study was to identify highest priority targets for future clinical and implementation trials in sub-Saharan Africa by assessing outcomes of a resource-adapted treatment protocol in Malawi. METHODS We conducted a retrospective cohort study of children treated for Wilms tumor with an adapted SIOP-backbone protocol in Lilongwe, Malawi between 2016 and 2021. Survival analysis assessed variables associated with poor outcome with high potential for future research and intervention. RESULTS We identified 136 patients, most commonly with stage III (n = 35; 25.7%) or IV disease (n = 35; 25.7%). Two-year event-free survival (EFS) was 54% for stage I/II, 51% for stage III, and 13% for stage IV. A single patient with stage V disease survived to 1 year. Treatment abandonment occurred in 36 (26.5%) patients. Radiotherapy was indicated for 55 (40.4%), among whom three received it. Of these 55 patients, 2-year EFS was 31%. Of 14 patients with persistent metastatic pulmonary disease at the time of nephrectomy, none survived to 2 years. Notable variables independently associated with survival were severe acute malnutrition (hazard ratio [HR]: 1.9), increasing tumor stage (HR: 1.5), and vena cava involvement (HR: 3.1). CONCLUSION High-impact targets for clinical and implementation trials in low-resource settings include treatment abandonment, late presentation, and approaches optimized for healthcare systems with persistently unavailable radiotherapy.
Collapse
Affiliation(s)
- David M Holmes
- Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | - Apatsa Matatiyo
- University of North Carolina Project Malawi, Lilongwe, Malawi
| | - Atupele Mpasa
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
| | - Minke H W Huibers
- Department of Outreach, Princess Maxima Center, Utrecht, Netherlands
| | - Geoffrey Manda
- Global Health Institute, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium
| | - Tamiwe Tomoka
- University of North Carolina Project Malawi, Lilongwe, Malawi
- Kamuzu University of Health Sciences, Blantyre, Malawi
| | - Maurice Mulenga
- Department of Pathology, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Ruth Namazzi
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Makerere University College of Health Sciences, Kampala, Uganda
| | - Parth Mehta
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Mark Zobeck
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Rizine Mzikamanda
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | | | - Carl Allen
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Jed G Nuchtern
- Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | - Eric Borgstein
- Department of Surgery, University of Malawi College of Medicine, Zomba, Malawi
| | - Daniel C Aronson
- Department of Surgery, University Children's Hospital Zürich, Zürich, Switzerland
| | - Nmazuo Ozuah
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Bip Nandi
- Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
- Department of Surgery, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Casey L McAtee
- Global Hematology-Oncology pediatric Excellence (HOPE), Houston, Texas, USA
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| |
Collapse
|
15
|
Lemmen J, Njuguna F, Verhulst S, Vik TA, Ket JCF, Kaspers G, Mostert S. Late Effects of Childhood Cancer Survivors in Africa: a Scoping Review. Crit Rev Oncol Hematol 2023; 185:103981. [PMID: 37003444 DOI: 10.1016/j.critrevonc.2023.103981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 03/28/2023] [Accepted: 03/29/2023] [Indexed: 04/03/2023] Open
Abstract
INTRODUCTION The number of children surviving cancer in Africa is increasing. Knowledge about late effects of survivors is lacking. Our study maps literature regarding late effects of childhood cancer survivors in Africa. METHODS Scoping review was performed following JBI-guidelines. Systematic literature search was conducted in: Medline, Embase, African Index Medicus, Web of Science, Scopus, Psycinfo. Titles and abstracts were screened by two reviewers, followed by full-text analysis by the lead reviewer. RESULTS Sixty-eight studies were included for content analysis. Studies originated from 10 of 54 African countries. Most studies had retrospective study design, 2-5 years follow-up, solely chemotherapy as treatment modality, Egypt as country of origin. Fifty-three studies described physical, and seventeen studies described psychosocial late effects. CONCLUSION Literature concerning late effects is available from a limited number of African countries. Psychosocial domain lacks attention compared to the physical domain. More countries should report on this topic to prevent, identify and monitor late effects.
Collapse
Affiliation(s)
- Jesse Lemmen
- Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, the Netherlands; Princess Máxima Center for Pediatric oncology, Utrecht, the Netherlands.
| | - Festus Njuguna
- Department of Child Health and Pediatrics, Moi Teaching and Referral Hospital, Moi University, Eldoret, Kenya
| | - Sanne Verhulst
- Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, the Netherlands
| | - Terry A Vik
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
| | | | - Gertjan Kaspers
- Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, the Netherlands; Princess Máxima Center for Pediatric oncology, Utrecht, the Netherlands
| | - Saskia Mostert
- Emma's Children Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric oncology, the Netherlands; Princess Máxima Center for Pediatric oncology, Utrecht, the Netherlands
| |
Collapse
|